Single Dose Of Minimally Invasive Treatment Resolves Some Vitreomacular Traction Cases

Monday, September 3, 2012

Ocular Surgery News

Ocriplasmin has a favorable safety profile and may provide a minimally invasive pharmacologic treatment for patients with vitreomacular traction and full-thickness macular hole, according to a speaker.

Full Story

Which of the following is not consistent with a classic diagnosis of multiple evanescent white dot syndrome (MEWDS)?
1. Unilateral involvement
2. Foveal involvement of the white dots
3. Vitreous cell
4. Venous sheathing
5. Optic nerve edema
Check The Answer

SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product
Volk iNview
iPhone Fundus Camera The Volk iNview ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Single Dose Of Minimally Invasive Treatment Resolves Some Vitreomacular Traction Cases

Comments

Quick Quiz

Which of the following is not consistent with a classic diagnosis of multiple evanescent white dot syndrome (MEWDS)?

AdGlare RMR Ad

Featured Products

SPECTRALIS Diagnostic Imaging Platform

Volk iNview

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2